Remus Pharmaceuticals (NSE:REMUS) Operating Cash Flow per Share : ₹26.96 (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Operating Cash Flow per Share?

Remus Pharmaceuticals's operating cash flow per share for the six months ended in Sep. 2024 was ₹17.33. Remus Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹26.96.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 42.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Remus Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

NSE:REMUS' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 42.2 Med: 42.2 Max: 42.2
Current: 42.2

During the past 4 years, Remus Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 42.20% per year. The lowest was 42.20% per year. And the median was 42.20% per year.

NSE:REMUS's 3-Year OCF Growth Rate is ranked better than
82.5% of 80 companies
in the Medical Distribution industry
Industry Median: 3.25 vs NSE:REMUS: 42.20

Remus Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Remus Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Operating Cash Flow per Share Chart

Remus Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar24

Operating Cash Flow per Share

2.21

4.82

8.55

6.36

Remus Pharmaceuticals Semi-Annual Data
	Mar20	Mar21	Mar22	Sep23	Mar24	Sep24
Operating Cash Flow per Share	Get a 7-Day Free Trial			-	-	-3.81	9.62	17.33

Competitive Comparison of Remus Pharmaceuticals's Operating Cash Flow per Share

For the Medical Distribution subindustry, Remus Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Remus Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Remus Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Remus Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )	=	Cash Flow from Operations (A: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2024 )
	=	36.024	/	5.668
	=	6.36

Remus Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )	=	Cash Flow from Operations (Q: Sep. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
	=	102.12	/	5.892
	=	17.33

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹26.96

Remus Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054

Website

https://www.remuspharma.com

Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines